This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

UPC Appeal Court grants Insulet provisional injunction against EOFlow’s insulin pump sales

( May 2, 2025, 07:56 GMT | Official Statement) -- MLex Summary: The Unified Patent Court’s Court of Appeal has granted a provisional injunction to US company Insulet against South Korea’s EOFlow, finding a likely infringement of Insulet’s EP 4,201,327 for an insulin pump device. The court overruled a lower decision, confirming the patent's validity and the risk of continued infringement. It emphasized Insulet's potential market loss if the competing device remained on the market. The injunction prevents EOFlow from distributing the infringing product in UPC member states until a final ruling, which is expected around December.The order is attached. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections